Kogan Yakov 4
4 · CLEVELAND BIOLABS INC · Filed Jan 25, 2012
Insider Transaction Report
Form 4
Kogan Yakov
DirectorCOO, Secretary
Transactions
- Award
Employee Stock Options (Right to Buy)
2012-01-23+56,250→ 56,250 totalExercise: $3.35From: 2012-01-23Exp: 2022-01-23→ Common Stock (56,250 underlying)
Footnotes (1)
- [F1]On January 23, 2012, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Dr. Kogan per the 2011 Executive Compensation Plan.